Literature DB >> 20810810

Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in bihar, India.

Roshan K Topno1, Vidya N R Das, Alok Ranjan, Krishna Pandey, Dharmender Singh, Nawin Kumar, Niyamat A Siddiqui, Vijay P Singh, Shreekant Kesari, Narendra Kumar, Sanjeev Bimal, Annadurai Jeya Kumar, Chetram Meena, Ranjeet Kumar, Pradeep Das.   

Abstract

A prospective study was carried out in a cohort of 355 persons in a leishmaniasis-endemic village of the Patna District in Bihar, India, to determine the prevalence of asymptomatic persons and rate of progression to symptomatic visceral leishmaniasis (VL) cases. At baseline screening, 50 persons were positive for leishmaniasis by any of the three tests (rK39 strip test, direct agglutination test, and polymerase chain reaction) used. Point prevalence of asymptomatic VL was 110 per 1,000 persons and the rate of progression to symptomatic cases was 17.85 per 1,000 person-months. The incidence rate ratio of progression to symptomatic case was 3.36 (95% confidence interval [CI] = 0.75-15.01, P = 0.09) among case-contacts of VL compared with neighbors. High prevalence of asymptomatic persons and clinical VL cases and high density of Phlebotomus argentipes sand flies can lead to transmission of VL in VL-endemic areas.

Entities:  

Mesh:

Year:  2010        PMID: 20810810      PMCID: PMC2929041          DOI: 10.4269/ajtmh.2010.09-0345

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  25 in total

1.  Kala-azar--progress against a neglected disease.

Authors:  Henry W Murray
Journal:  N Engl J Med       Date:  2002-11-28       Impact factor: 91.245

2.  Leishmania donovani in blood smears of asymptomatic persons.

Authors:  M C Sharma; A K Gupta; V N Das; N Verma; N Kumar; R Saran; S K Kar
Journal:  Acta Trop       Date:  2000-09-18       Impact factor: 3.112

3.  Serological diagnosis of Indian visceral leishmaniasis: direct agglutination test versus rK39 strip test.

Authors:  S Sundar; R K Singh; R Maurya; B Kumar; A Chhabra; V Singh; M Rai
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-12-02       Impact factor: 2.184

4.  Evaluation of PCR for diagnosis of visceral leishmaniasis.

Authors:  O F Osman; L Oskam; E E Zijlstra; N C Kroon; G J Schoone; E T Khalil; A M El-Hassan; P A Kager
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

5.  Usefulness of the direct agglutination test in the early detection of subclinical Leishmania donovani infection: a community-based study.

Authors:  S Bimal; V N R Das; P K Sinha; A K Gupta; N Verma; A Ranjan; S K Singh; A Sen; S K Bhattacharya; P Das
Journal:  Ann Trop Med Parasitol       Date:  2005-12

Review 6.  Leishmaniasis. Public health aspects and control.

Authors:  P Desjeux
Journal:  Clin Dermatol       Date:  1996 Sep-Oct       Impact factor: 3.541

7.  Asymptomatic Leishmania chagasi infection in relatives and neighbors of patients with visceral leishmaniasis.

Authors:  A D'Oliveira Júnior; S R Costa; A B Barbosa; G Orge M de la; E M Carvalho
Journal:  Mem Inst Oswaldo Cruz       Date:  1997 Jan-Feb       Impact factor: 2.743

8.  Mapping of risk prone areas of kala-azar (Visceral leishmaniasis) in parts of Bihar State, India: an RS and GIS approach.

Authors:  S Sudhakar; T Srinivas; A Palit; S K Kar; S K Battacharya
Journal:  J Vector Borne Dis       Date:  2006-09       Impact factor: 1.688

9.  Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen.

Authors:  Sarman Singh; Veena Kumari; Niti Singh
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

10.  Epidemiology of visceral leishmaniasis in northeast Brazil.

Authors:  T G Evans; M J Teixeira; I T McAuliffe; I Vasconcelos; A W Vasconcelos; A de A Sousa; J W Lima; R D Pearson
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

View more
  47 in total

1.  Serological and Molecular Analysis of Leishmania Infection in Healthy Individuals from Two Districts of West Bengal, India, Endemic for Visceral Leishmaniasis.

Authors:  Himanshu Kaushal; Sujit Kumar Bhattacharya; Sandeep Verma; Poonam Salotra
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

2.  Parasite load estimation by qPCR differentiates between asymptomatic and symptomatic infection in Indian visceral leishmaniasis.

Authors:  Medhavi Sudarshan; Shyam Sundar
Journal:  Diagn Microbiol Infect Dis       Date:  2014-03-07       Impact factor: 2.803

3.  Asymptomatic Visceral Leishmania infantum Infection in US Soldiers Deployed to Iraq.

Authors:  Rupal M Mody; Ines Lakhal-Naouar; Jeffrey E Sherwood; Nancy L Koles; Dutchabong Shaw; Daniel P Bigley; Edgie-Mark A Co; Nathanial K Copeland; Linda L Jagodzinski; Rami M Mukbel; Rebecca A Smiley; Robert C Duncan; Shaden Kamhawi; Selma M B Jeronimo; Robert F DeFraites; Naomi E Aronson
Journal:  Clin Infect Dis       Date:  2019-05-30       Impact factor: 9.079

4.  New challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas.

Authors:  Kathryn M Dupnik; Eliana L Nascimento; Joao F Rodrigues-Neto; Tatjana Keesen; Maria Zélia Fernandes; Iraci Duarte; Selma M B Jeronimo
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

Review 5.  Molecular Diagnosis of Visceral Leishmaniasis.

Authors:  Shyam Sundar; Om Prakash Singh
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

6.  Asymptomatic Leishmania infection: a new challenge for Leishmania control.

Authors:  Om Prakash Singh; Epco Hasker; David Sacks; Marleen Boelaert; Shyam Sundar
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

7.  Visceral leishmaniasis prevalence and associated risk factors in the saran district of Bihar, India, from 2009 to July of 2011.

Authors:  Diana Perry; Kandice Dixon; Rajesh Garlapati; Alex Gendernalik; David Poché; Richard Poché
Journal:  Am J Trop Med Hyg       Date:  2013-02-04       Impact factor: 2.345

8.  Endemic transmission of visceral leishmaniasis in Bhutan.

Authors:  Thinley Yangzom; Israel Cruz; Caryn Bern; Daniel Argaw; Margriet den Boer; Iván Dario Vélez; Sujit K Bhattacharya; Ricardo Molina; Jorge Alvar
Journal:  Am J Trop Med Hyg       Date:  2012-10-22       Impact factor: 2.345

9.  Detection of Leishmania donovani in peripheral blood of asymptomatic individuals in contact with patients with visceral leishmaniasis.

Authors:  Sultana S Banu; Wieland Meyer; Be-Nazir Ahmed; Rady Kim; Rogan Lee
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-05       Impact factor: 2.184

10.  Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis.

Authors:  A C Vallur; M S Duthie; C Reinhart; Y Tutterrow; S Hamano; K R H Bhaskar; R N Coler; D Mondal; S G Reed
Journal:  Clin Microbiol Infect       Date:  2013-11-18       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.